chr12:25209904:T>A Detail (hg38) (KRAS)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr12:25,362,838-25,362,838 View the variant detail on this assembly version. |
| hg38 | chr12:25,209,904-25,209,904 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
| RefSeq | NM_004985.4:c.458A>T | NP_004976.2:p.Asp153Val |
| NM_033360.3:c.458A>T | NP_203524.1:p.Asp153Val | |
| Ensemble | ENST00000256078.10:c.*12A>T |
Summary
MGeND
| Clinical significance |
|
| Variant entry | 2 |
| GWAS entry | |
| Disease area statistics | Show details |
Disease area statistics
MGeND
| Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
|---|---|---|---|---|---|---|---|---|---|
|
|
cardiofaciocutaneous syndrome |
|
MGS000001
(TMGS000137) |
Kenjiro Kosaki | Keio University | ||||
|
|
other |
|
MGS000001
(TMGS000183) |
Kenjiro Kosaki | Keio University |
ClinVar
| Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
|---|---|---|---|---|---|
|
|
2006-03-01 | no assertion criteria provided | cardiofaciocutaneous syndrome 2 |
|
Detail |
|
|
2023-10-09 | criteria provided, multiple submitters, no conflicts | Noonan syndrome 3 |
|
Detail |
|
|
2023-08-01 | criteria provided, single submitter | RASopathy |
|
Detail |
|
|
2023-06-13 | criteria provided, multiple submitters, no conflicts | not provided |
|
Detail |
|
|
2017-04-20 | criteria provided, single submitter | not specified |
|
Detail |
|
|
2018-11-15 | reviewed by expert panel | Noonan syndrome |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2018-10-31 | criteria provided, single submitter | Carcinoma of pancreas,autoimmune lymphoproliferative syndrome type 4,Familial cancer of breast,acute myeloid leukemia,Hereditary diffuse gastric adenocarcinoma,lung carcinoma,linear nevus sebaceous syndrome,cardiofaciocutaneous syndrome 2,Malignant tumor of urinary bladder,Noonan syndrome 3,Cerebral arteriovenous malformation |
|
Detail |
|
|
2014-05-12 | criteria provided, single submitter | Cardio-facio-cutaneous syndrome,Noonan syndrome |
|
Detail |
|
|
2014-05-12 | criteria provided, single submitter | Cardio-facio-cutaneous syndrome,Noonan syndrome |
|
Detail |
|
|
no assertion criteria provided | Noonan syndrome 1 |
|
Detail | |
|
|
2022-09-08 | criteria provided, single submitter |
|
Detail |
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.240 | cardiofaciocutaneous syndrome 2 | NA | CLINVAR | Detail | |
| 0.440 | Noonan syndrome 3 | NA | CLINVAR | Detail | |
| 0.244 | Cardio-facio-cutaneous syndrome | We discovered de novo germline KRAS mutations that introduce V14I, T58I or D153V... | BeFree | 16474405 | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND Cardiofaciocutaneous syndrome 2 | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND Noonan syndrome 3 | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND RASopathy | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND not provided | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND not specified | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND Noonan syndrome | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND multiple conditions | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND Noonan syndrome 1 | ClinVar | Detail |
| NM_004985.5(KRAS):c.458A>T (p.Asp153Val) AND Cardiovascular phenotype | ClinVar | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We discovered de novo germline KRAS mutations that introduce V14I, T58I or D153V amino acid substitu... | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs104894360 dbSNP
- Genome
- hg38
- Position
- chr12:25,209,904-25,209,904
- Variant Type
- snv
- Reference Allele
- T
- Alternative Allele
- A
Genome browser
